ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 윌슨병 치료제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 6.5%, 8억 5,000만 달러로 성장할 것으로 예상됩니다. 이러한 성장 예측은 혁신적인 의약품 연구와 유전자 치료에 대한 투자 증가, 맞춤형 의료 급증, 환자 교육 이니셔티브 확대, 건강 관리 지출 증가, 규제 당국 승인 확대 등이 배경에 있습니다. 예측기간 동안 예상되는 주요 동향으로는 유전자 치료의 발전, 질병 개발 추적을 위한 바이오마커의 응용 확대, 디지털 헬스케어 솔루션의 통합, 희소질환용 의약품의 인정에 의한 폭넓은 인지, 투자 증가, 병용 치료 전략의 출현 등이 있습니다.
유전성 질환의 이환율 증가는 윌슨병 치료제 시장의 성장을 가속할 것으로 예측됩니다. 유전성 질환은 돌연변이, 결실, 염색체 변화 등 개인의 DNA 이상으로 인해 발생합니다. 유전성 질환 증가는 주로 부모의 나이가 높아지고 유전 가능한 돌연변이가 자손에게 계승될 가능성이 높아지기 때문입니다. 윌슨병 치료제는 ATP7B 유전자의 돌연변이로 인한 유해한 구리의 축적을 줄임으로써 이 유전적 상태를 치료하는 데 사용됩니다. 이 약들은 구리 배설을 촉진하거나 흡수를 억제함으로써 간과 뇌와 같은 중요한 기관을 보호합니다. 예를 들어 영국을 거점으로 하는 국립자선단체 'Cystic Fibrosis Trust'에 따르면 2023년 9월 영국에서 낭포성 섬유증에 등록된 환자수는 2021년 1만 908명에서 2022년 1만1148명으로 증가했습니다. 그 결과 유전성 질환의 유병률 증가가 윌슨병 치료제 시장의 확대를 뒷받침하고 있습니다.
윌슨병 치료제 시장의 주요 기업은 염산 트리엔틴(TETA-4HCl) 등의 선진적인 제제를 개발하여 치료 성적 향상과 희귀질환 관리에 있어서 환자의 편의성 향상에 노력하고 있습니다. 트리엔틴 테트라하이드로클로라이드(TETA-4HCl)는 안정된 윌슨병 성인 환자의 구리 균형을 유지하기 위해 조정된 첨단 경구 구리 킬레이트 요법입니다. 2023년 4월, 프랑스에 거점을 둔 희귀질환용 의약품의 개발과 상업화를 전문으로 하는 Orphalan SA는 Cuvrior를 발표했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 윌슨병 치료제 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 윌슨병 치료제 시장 : 성장률 분석
세계의 윌슨병 치료제 시장 실적 : 규모와 성장, 2019-2024년
세계의 윌슨병 치료제 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 윌슨병 치료제 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 윌슨병 치료제 시장 : 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
킬레이트제
아연요법
간 이식
대증요법
세계의 윌슨병 치료제 시장 : 투여 경로별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
경구
정맥내
피하
세계의 윌슨병 치료제 시장 : 유통 채널별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 윌슨병 치료제 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
홈케어
전문 클리닉
기타 최종 사용자
세계의 윌슨병 치료제 시장 : 킬레이트제 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
페니실라민
트리엔틴
테트라티오몰리브덴산염
실험적 킬레이트제
세계의 윌슨병 치료제 시장 : 아연 치료 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
아세트산아연
글루콘산아연
황산아연
세계의 윌슨병 치료제 시장 : 간 이식 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
동소성 간 이식
생체 간 이식
뇌사 기증자 간 이식
세계의 윌슨병 치료제 시장 : 대증 치료 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
항정신병제
항 간질 약
항우울제
근육 이완제
항콜린제
제7장 지역별/국가별 분석
세계의 윌슨병 치료제 시장 : 지역별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 윌슨병 치료제 시장 : 국가별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
윌슨병 치료제 시장 : 경쟁 구도
윌슨병 치료제 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
AstraZeneca plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Teva Pharmaceutical Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bausch Health Companies Inc.
Intas Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories
Lupin Pharmaceuticals
Ultragenyx Pharmaceutical Inc.
Taj Pharmaceutical Limited
Biophore Pharma Inc.
Orphalan SA
Nobelpharma Co. Ltd
Eton Pharmaceuticals
LogicBio Therapeutics
DepYmed
Vivet Therapeutics
Telomir Pharmaceuticals Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
윌슨병 치료제 시장(2029년) : 새로운 기회를 제공하는 국가
윌슨병 치료제 시장(2029년) : 새로운 기회를 제공하는 부문
윌슨병 치료제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Wilson's disease drugs are treatments used to address a rare inherited disorder that causes excessive copper accumulation, primarily in the liver and brain. These medications function by either promoting the elimination of copper from the body or preventing its absorption. Their main goal is to avoid or reverse damage to organs, especially the liver and nervous system.
The key categories of Wilson's disease drugs include chelating agents, zinc-based therapies, liver transplantation, and supportive symptom management. Chelating agents help manage Wilson's disease by binding to surplus copper, allowing it to be excreted through urine, thereby quickly decreasing copper toxicity. These drugs are administered via oral, intravenous, and subcutaneous routes and are distributed through hospital pharmacies, retail outlets, online platforms, and other channels. They are utilized by various end-users, such as hospitals, home care providers, specialty clinics, and more.
The wilson's disease drugs market research report is one of a series of new reports from The Business Research Company that provides wilson's disease drugs market statistics, including the wilson's disease drugs industry global market size, regional shares, competitors with the wilson's disease drugs market share, detailed wilson's disease drugs market segments, market trends, opportunities, and any further data you may need to thrive in the wilson's disease drugs industry. This Wilson's disease drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The wilson's disease drugs market size has grown strongly in recent years. It will grow from $0.62 billion in 2024 to $0.66 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The historical growth can be linked to increased awareness about Wilson's disease and its symptoms, expanded clinical research activities, broader access to standardized treatments, improvements in healthcare infrastructure, and a higher number of diagnosed patients.
The wilson's disease drugs market size is expected to see strong growth in the next few years. It will grow to $0.85 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. This projected growth is driven by higher investments in innovative drug research and gene therapy, a surge in personalized medicine practices, expansion of patient education initiatives, increased healthcare expenditure, and more regulatory approvals. Key trends expected during the forecast period include advancements in gene therapy, increased application of biomarkers to track disease development, integration of digital healthcare solutions, broader recognition through orphan drug status, rising investments, and the emergence of combination treatment strategies.
The rising incidence of genetic disorders is anticipated to drive the growth of the Wilson's disease drugs market. Genetic disorders result from abnormalities in an individual's DNA, including mutations, deletions, or chromosomal changes. The increase in genetic disorders is primarily attributed to higher parental age, which elevates the likelihood of inheritable mutations being passed to offspring. Wilson's disease drugs are used to treat this genetic condition by reducing harmful copper accumulation caused by ATP7B gene mutations. These drugs work by promoting copper excretion or inhibiting its absorption, thereby protecting vital organs such as the liver and brain. For example, according to the Cystic Fibrosis Trust, a UK-based national charity, in September 2023, the number of patients in the UK registered with cystic fibrosis rose to 11,148 in 2022, up from 10,908 in 2021. Consequently, the increasing prevalence of genetic disorders is supporting the expansion of the Wilson's disease drugs market.
Leading companies in the Wilson's disease drug market are developing advanced drug formulations, such as trientine tetrahydrochloride (TETA-4HCl), to improve treatment outcomes and enhance patient convenience in managing rare diseases. Trientine tetrahydrochloride (TETA-4HCl) is an advanced oral copper-chelating therapy tailored to maintain copper balance in adult patients with stable Wilson's disease. For instance, in April 2023, Orphalan SA, a France-based company specializing in orphan drug development and commercialization, introduced Cuvrior. Approved by the Food and Drug Administration (FDA) and granted Orphan Drug Exclusivity, Cuvrior is a new trientine tetrahydrochloride (TETA-4HCl) formulation designed for adults with stable Wilson's disease who are already decoppered and tolerant to penicillamine. It offers a room temperature-stable oral therapy that enhances dosing flexibility and convenience compared to earlier treatments.
In January 2025, Eton Pharmaceuticals, a US-based pharmaceutical company, acquired Galzin from Teva Pharmaceuticals USA for an undisclosed amount. This acquisition reflects Eton Pharmaceuticals' dedication to rare disease treatments by adding an FDA-approved therapy for the ultra-rare metabolic condition Wilson's disease to its portfolio. Teva Pharmaceuticals USA, Inc. is a US-based pharmaceutical manufacturer of Wilson's disease drugs.
Major players in the wilson's disease drugs market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Lupin Pharmaceuticals, Ultragenyx Pharmaceutical Inc., Taj Pharmaceutical Limited, Biophore Pharma Inc., Orphalan SA, Nobelpharma Co. Ltd, Eton Pharmaceuticals, LogicBio Therapeutics, DepYmed, Vivet Therapeutics, Telomir Pharmaceuticals Inc., and Innorna.
North America was the largest region in the wilson's disease drugs market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Wilson's Disease Drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The wilson's disease drugs market consists of sales of zinc salts, penicillamine, and trientine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Wilson's Disease Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on wilson's disease drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for wilson's disease drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wilson's disease drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Wilson's Disease Drugs Market Characteristics
3. Wilson's Disease Drugs Market Trends And Strategies
4. Wilson's Disease Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Wilson's Disease Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Wilson's Disease Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Wilson's Disease Drugs Market Growth Rate Analysis
5.4. Global Wilson's Disease Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Wilson's Disease Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Wilson's Disease Drugs Total Addressable Market (TAM)
6. Wilson's Disease Drugs Market Segmentation
6.1. Global Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chelating Agents
Zinc Therapy
Liver Transplant
Symptomatic Treatments
6.2. Global Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Subcutaneous
6.3. Global Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacies
Other Distribution Channels
6.4. Global Wilson's Disease Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End-Users
6.5. Global Wilson's Disease Drugs Market, Sub-Segmentation Of Chelating Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Penicillamine
Trientine
Tetrathiomolybdate
Experimental Chelators
6.6. Global Wilson's Disease Drugs Market, Sub-Segmentation Of Zinc Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Zinc Acetate
Zinc Gluconate
Zinc Sulfate
6.7. Global Wilson's Disease Drugs Market, Sub-Segmentation Of Liver Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Orthotopic Liver Transplantation
Living Donor Liver Transplantation
Deceased Donor Liver Transplantation
6.8. Global Wilson's Disease Drugs Market, Sub-Segmentation Of Symptomatic Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antipsychotic Medications
Antiepileptic Drugs
Antidepressants
Muscle Relaxants
Anticholinergics
7. Wilson's Disease Drugs Market Regional And Country Analysis
7.1. Global Wilson's Disease Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Wilson's Disease Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Wilson's Disease Drugs Market
9.1. China Wilson's Disease Drugs Market Overview
9.2. China Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Wilson's Disease Drugs Market
10.1. India Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Wilson's Disease Drugs Market
11.1. Japan Wilson's Disease Drugs Market Overview
11.2. Japan Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Wilson's Disease Drugs Market
12.1. Australia Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Wilson's Disease Drugs Market
13.1. Indonesia Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Wilson's Disease Drugs Market
14.1. South Korea Wilson's Disease Drugs Market Overview
14.2. South Korea Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Wilson's Disease Drugs Market
15.1. Western Europe Wilson's Disease Drugs Market Overview
15.2. Western Europe Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Wilson's Disease Drugs Market
16.1. UK Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Wilson's Disease Drugs Market
17.1. Germany Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Wilson's Disease Drugs Market
18.1. France Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Wilson's Disease Drugs Market
19.1. Italy Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Wilson's Disease Drugs Market
20.1. Spain Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Wilson's Disease Drugs Market
21.1. Eastern Europe Wilson's Disease Drugs Market Overview
21.2. Eastern Europe Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Wilson's Disease Drugs Market
22.1. Russia Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Wilson's Disease Drugs Market
23.1. North America Wilson's Disease Drugs Market Overview
23.2. North America Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Wilson's Disease Drugs Market
24.1. USA Wilson's Disease Drugs Market Overview
24.2. USA Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Wilson's Disease Drugs Market
26.1. South America Wilson's Disease Drugs Market Overview
26.2. South America Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Wilson's Disease Drugs Market
27.1. Brazil Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Wilson's Disease Drugs Market
28.1. Middle East Wilson's Disease Drugs Market Overview
28.2. Middle East Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Wilson's Disease Drugs Market
29.1. Africa Wilson's Disease Drugs Market Overview
29.2. Africa Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Wilson's Disease Drugs Market Competitive Landscape And Company Profiles
